Remifemin
This article was originally published in The Tan Sheet
Executive Summary
GSK did not provide International Menopause Society with unrestricted educational grant to create Powering Informed Choices Initiative, which promotes firm's Remifemin, as stated in 1"The Tan Sheet" Oct. 29, p. 13...
You may also be interested in...
Menopause Herbals Viewed Warily By Patients & Doctors, Surveys Show
Soy, vitamin E and black cohosh are the dietary supplement ingredients that doctors feel most comfortable recommending to their patients for menopause, according to a recent Southern California University of Health Sciences survey.
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.